<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>sc - Tag - MilkyÊùøÊùø„ÅÆÂçöÂÆ¢</title>
        <link>https://uioqps.github.io/tags/sc/</link>
        <description>sc - Tag - MilkyÊùøÊùø„ÅÆÂçöÂÆ¢</description>
        <generator>Hugo -- gohugo.io</generator><language>en</language><copyright>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</copyright><lastBuildDate>Sun, 23 Feb 2020 21:16:02 &#43;0000</lastBuildDate><atom:link href="https://uioqps.github.io/tags/sc/" rel="self" type="application/rss+xml" /><item>
    <title>„Äêbioinfo„Äë-Q&amp;A-75</title>
    <link>https://uioqps.github.io/bioinfo-q-a-75/</link>
    <pubDate>Sun, 23 Feb 2020 21:16:02 &#43;0000</pubDate>
    <author>Milky</author>
    <guid>https://uioqps.github.io/bioinfo-q-a-75/</guid>
    <description><![CDATA[single cell Â¶Ç‰ΩïÁ†îÁ©∂ÂÆø‰∏ªÁªÜËÉûÂíåÁóÖÂéü‰Ωì‰πãÈó¥ÁöÑÂÖ≥Á≥ª  Single-Cell RNA Sequencing to Understand Host‚àíPathogen Interactions
 Á†îÁ©∂ÁóÖÂéü‰Ωì‰∏∫‰ªÄ‰πàË¶ÅÁî®ÂçïÁªÜËÉûÊµãÂ∫èÔºü ‰∏∫‰ªÄ‰πàË¶ÅÂÅöÂçïÁªÜËÉûÊµãÂ∫èÔºåÂÖ∂ÂÆûÂ∑≤ÁªèÊòØ‰∏çË®ÄËÄåÂñªÁöÑ‰∫ÜÔºå‰ªé‰∏ãÈù¢‰∏ÄÂπÖÂõæ‰πüËÉΩ‰ΩìÁé∞Âá∫Êù•„ÄÇÁ±ª‰ººËÇøÁò§ÁöÑÂºÇË¥®ÊÄßÔºåÂæÆÁîüÁâ©ÔºåÂ¶ÇÁªÜËèå‰πüÂ≠òÂú®ÂæàÂº∫ÁöÑËèåÁæ§ÂºÇË¥®ÊÄßÔºåÈô§‰∫ÜÁªÜËèåÁöÑ‰∫öÂÖãÈöÜ‰πãÂ§ñÔºåËøòÊúâÂêàÂπ∂ÊÑüÊüìÁ≠âÂ§çÊùÇÁöÑÁé∞Ë±°„ÄÇÂ¶ÇÂõæÊâÄÁ§∫ÁöÑ‰∏âÁßçÁªÜËÉûÁæ§‰ΩìÁâπÂæÅÔºåÂèØËÉΩÂú®bulkÊµãÂ∫èÂêéÂæóÂà∞Áõ∏ÂêåÁöÑË°®ÂûãÔºåÂõ†Ê≠§ËÄåÊé©Áõñ‰∫ÜÁúüÂÆûÁöÑÁé∞Ë±°„ÄÇ‰∏Ä‰∏™ÂÖ∏ÂûãÁöÑ‰æãÂ≠êÂá∫Áé∞Âú®Â§ßËÇ†ÊùÜËèåE.coliÂèåÁ®≥ÊÄÅÔºàbistabilityÔºâÁöÑÁ†îÁ©∂‰∏≠„ÄÇÂèåÁ®≥ÊÄÅÊèèËø∞‰∫Ü‰∏ÄÁßçÂèØÈÄÜÁöÑÂèåÂ≥∞Âü∫Âõ†Ë°®ËææÔºåÂØºËá¥‰∏§‰∏™‰∏çÂêåÁöÑÂÖ±Â≠ò‰∫öÁæ§„ÄÇÈù¢ÂØπÊäóÁîüÁ¥†Êö¥Èú≤Ôºå‰∏ÄÂ∞èÈÉ®ÂàÜÁªÜËèåÁæ§‰Ωì‰ºöËΩ¨ÂåñÊàêÊåÅ‰πÖÁªÜËÉûÔºàpersister cellsÔºâÔºå‰ªçÁÑ∂‰ª•ÊûÅ‰ΩéÁöÑÁîüÈïøÈÄüÂ∫¶Â≠òÊ¥ª„ÄÇ
Èô§‰∫ÜÁªÜËèåÁöÑËèåÁæ§ÂºÇË¥®ÊÄßÂíåÂ∑≤Áü•ÁöÑÂÆø‰∏ªÔºàÂÖçÁñ´ÔºâÁªÜËÉûÁöÑÂºÇË¥®ÊÄßÔºåÁªÜËèåÂú®ÂÆø‰∏ªÁªÜËÉû‰∏≠ÁöÑÂØÑÁîüÁä∂ÊÄÅÁöÑÂ§öÊ†∑ÊÄßÂíåÂä®ÊÄÅÂèòÂåñÂèà‰ΩøÂæóËøôÁ±ªÁ†îÁ©∂ÁöÑÂ§çÊùÇÁ®ãÂ∫¶Êõ¥‰∏ä‰∏ÄÂ±ÇÊ•º„ÄÇÂΩìÁªÜËèåÊé•Ëß¶Âà∞ÂÆø‰∏ªÁªÜËÉûÊó∂ÔºåÁªÜËèåÂèØËÉΩÂÜÖÂåñÔºå‰πüÂèØËÉΩ‰∏çÂèëÁîüÂÜÖÂåñ„ÄÇÂΩìÁªÜËèåÂÜÖÂåñÂèëÁîü‰∫ÜÔºåÂÆø‰∏ªÁªÜËÉû‰ΩúÂá∫ÁöÑÂ∫îÁ≠îÊúâÂèØËÉΩÊòØÁîüÂ≠òÔºåÊ∏ÖÈô§ÊàñËÄÖÊ≠ª‰∫°„ÄÇÁîüÂ≠òÁä∂ÊÄÅ‰∏ãÔºåÁªÜËèåÂú®ÂÆø‰∏ªÁªÜËÉûÂÜÖÁöÑÂèØËÉΩÂèëÁîüÂ¢ûÊÆñÔºå‰πüÂèØËÉΩË¢´ÊäëÂà∂„ÄÇÊ≠ª‰∫°Áä∂ÊÄÅ‰∏ãÔºåÁªÜËèåÂèØËÉΩÂÖ±‰∫°‰πüÂèØËÉΩÈÄÉÈÄ∏„ÄÇ‰∏çÂêåÁöÑÊÑüÊüìÁªìÂ±ÄÂèØËÉΩÁî±‰∫éÁªÜËèåÁöÑË°®ËææË∞±Â∑ÆÂºÇÊàñËÄÖÂÆø‰∏ªÁªÜËÉûÁöÑË°®ËææË∞±Â∑ÆÂºÇÂØºËá¥„ÄÇËÄåÁõ∏ÂêåÁöÑÊÑüÊüìÁªìÂ±Ä‰πüÊúâÂèØËÉΩÊòØÊù•Ê∫ê‰∫éÂÖ∑ÊúâË°®ËææÂ∑ÆÂºÇÁöÑ‰∏çÂêåÁóÖÂéü‰Ωì-ÂÆø‰∏ªÁªÑÂêà„ÄÇÂê¨ÂÆåÊòØ‰∏çÊòØËßâÂæóÁâπÂà´ÊÉ≥ÂêêË°Äü§ÆÔºüÂçïÁªÜËÉûÊµãÂ∫èÂ∞±ÂÉè‰∏Ä‰∏™ÊîæÂ§ßÈïú‰∏ÄÊ†∑ÔºåÂèØ‰ª•ËÆ©Êàë‰ª¨Êõ¥ÁªÜËá¥ÁöÑËßÇÂØüÁóÖÂéü‰ΩìÊÑüÊüìÁöÑËøáÁ®ã„ÄÇÂõ†Ê≠§Êàë‰ª¨ÈùûÂ∏∏ÈúÄË¶ÅÂÆÉ„ÄÇ
Ë∂äÊù•Ë∂äÂ§öÁöÑÂçïÁªÜËÉûÊµãÂ∫èÊñπÊ≥ïÊ∂åÁé∞Âá∫Êù•ÔºåÂØπÊµãÂ∫èËøáÁ®ã‰∏≠‰ªª‰ΩïÁéØËäÇÁöÑÂÅèÂÄöÊúâ‰∫ÜË∂äÊù•Ë∂äÂ•ΩÁöÑ‰øÆÊ≠£ÊñπÊ°à„ÄÇÊ≠§Â§ñËøòÊúâÂïÜ‰∏öÂåñÁöÑÊµãÂ∫èÂπ≥Âè∞ÔºåÂ¶ÇFluidigm&rsquo;s C1Á≥ªÁªüÂíå10x GenomicsÔºå‰ΩøÂçïÁªÜËÉûÊµãÂ∫è‰ªéÁªÜËÉûÂàÜÈÄâ„ÄÅË£ÇËß£„ÄÅRNAÊèêÂèñ„ÄÅcDNAÂêàÊàêÂà∞Âª∫Â∫ìÊµãÂ∫èÂèòÊàêÊµÅÊ∞¥Á∫ø‰Ωú‰∏ö„ÄÇÈíàÂØπÂçïÁªÜËÉûÁöÑÊàêÂ•óÊï∞ÊçÆÂàÜÊûêÊñπÊ≥ï‰πü‰∏çÊñ≠Ë¢´ÂºÄÂèëÂá∫Êù•ÔºåÂ¶ÇSeuratÂíåSCDEÂ∑≤Êï¥Âêà‰∫ÜÂçïÁªÜËÉûÊµãÂ∫èÊï∞ÊçÆÂàÜÊûêÁöÑÂ§öÊ≠•ÂàÜÊûêÊµÅÁ®ã„ÄÇ
Â∞±ÂÉèÊòØÂΩìÂπ¥‰∫∫Á±ªÂü∫Âõ†ÁªÑËÆ°ÂàíÁöÑÂçáÁ∫ßÁâàÔºåÂ§öÈ°πÂçïÁªÜËÉûÂ±ÇÈù¢ÁöÑÁ†îÁ©∂ËÆ°ÂàíÁõÆÂâçÊ≠£Âú®ËøõË°å‰∏≠ÔºåÂ¶ÇChan ZuckerbergÁ†îÁ©∂ÊâÄÊîØÊåÅÁöÑThe Human Cell AtlasÔºåNIHÊîØÊåÅÁöÑHuman BioMolecular Atlas Program„ÄÇËøô‰∫õËÆ°Âàí‰∏≠ÁßëÂ≠¶ÂÆ∂‰ª¨Â∞ÜÂØπÊâÄÊúâ‰∫∫‰ΩìÁªÜËÉûÁ±ªÂûãÂíåÁªÑÁªáÁ±ªÂûãËøõË°åDNA„ÄÅRNAÂíåËõãÁôΩÊ∞¥Âπ≥ÁöÑÁ†îÁ©∂Ôºå‰ªéËÄåÂú®ÁªÜËÉûÊ∞¥Âπ≥Á†îÁ©∂Â§çÊùÇÊú∫‰ΩìÁöÑÁîüÁâ©Â••Áßò„ÄÇÈô§Ê≠§‰πãÂ§ñÔºåÈíàÂØπÊÑüÊüìÂíåÂÖçÁñ´È¢ÜÂüüÔºåImmunological Genome ProjectÈ°πÁõÆËÆ°ÂàíÈíàÂØπÂ∞èÈº†Ê®°ÂûãÔºåÊ£ÄÊµãÊâÄÊúâÂÖçÁñ´ÁªÜËÉû‰∫öÂûãÁöÑË°®ËææË∞±Êï∞ÊçÆÔºåÂª∫Á´ãÊï∞ÊçÆÂ∫ìÔºå‰∏∫Á†îÁ©∂ÂÖçÁñ´ÁªÜËÉûË°å‰∏∫ÔºåËøõÂåñÂíåÂèëÁé∞Êñ∞ÁöÑÂÖçÁñ´ÁªÜËÉû‰∫öÂûãÊèê‰æõÊîØÊåÅ„ÄÇËØ•Êï∞ÊçÆÂ∫ìÊî∂ÂΩï‰∫ÜÂ∞èÈº†Ê®°ÂûãÂú®‰∏çÂêåÊÑüÊüìÁñæÁóÖÁä∂ÊÄÅ‰∏ãÔºåÂÖçÁñ´ÁªÜËÉûÁöÑÂçïÁªÜËÉûÊµãÂ∫èÊï∞ÊçÆ„ÄÇ
ÂæÆÁîüÁâ©ÁóÖÂéü‰Ωì‰∏éÂÆø‰∏ªÂÖ≥Á≥ªÁöÑÁ†îÁ©∂ËøõÂ±ïÔºà‰∏æ‰æãÔºâ ÊúÄÊó©ÁöÑ‰∏§ÁØá‰ªéÂçïÁªÜËÉûÂ±ÇÈù¢Á†îÁ©∂ÂÆø‰∏ª-ÁªÜËèåÁõ∏‰∫íÂÖ≥Á≥ªÁöÑÊñáÁ´†Á†îÁ©∂‰∫ÜÈº†‰º§ÂØíÊ≤ôÈó®Ê∞èËèåÂíåÂÆø‰∏ªÂ∑®Âô¨ÁªÜËÉûÁöÑÁõ∏‰∫í‰ΩúÁî®„ÄÇÁ†îÁ©∂‰∏≠‰ªÖÂØπÂÆø‰∏ªÁªÜËÉûËøõË°å‰∫ÜÂçïÁªÜËÉûÊµãÂ∫èÔºåËÄåÁóÖÂéüËèåÂàôÊòØÂà©Áî®ËçßÂÖâÊ†áËÆ∞ËøõË°åÊ£ÄÊµã„ÄÇAvrahamÁ≠â‰∫∫Á†îÁ©∂ÂèëÁé∞ÁªÜËèåÁöÑÂèòÂºÇÊÄßÂÜ≥ÂÆö‰∫ÜÂÆø‰∏ªÁªÜËÉûÁöÑÂ∫îÁ≠îÂ∑ÆÂºÇ„ÄÇÊÑüÊüìÁöÑÂ∑®Âô¨ÁªÜËÉûÁöÑËΩ¨ÂΩïÁªÑÂàÜÊûêÊè≠Á§∫‰∫Ü‰∏ÄÁªÑÂèåÂ≥∞Ë°®ËææÂü∫Âõ†ÔºåÂÆÉ‰ª¨ÂØåÈõÜÂú®IÂûãÂπ≤Êâ∞Á¥†Â∫îÁ≠îÂèçÂ∫îÂäüËÉΩ‰∏ãÔºåÂπ∂‰∏î‰ªÖÂú®‰∏âÂàÜ‰πã‰∏ÄÁöÑÊÑüÊüìÁªÜËÉû‰∏≠Ë¢´ËØ±ÂØº„ÄÇËØ•Â∫îÁ≠îÂèçÂ∫îÁä∂ÊÄÅ‰∏éÁªÜËèåÁöÑPhoPQÂèåÁªÑÂàÜÁ≥ªÁªüÂØÜÂàáÁõ∏ÂÖ≥ÔºåÁî±ÁªÜËèåË°®Èù¢LPS‰ªãÂØº„ÄÇÁ†îÁ©∂Ëøõ‰∏ÄÊ≠•ÂèëÁé∞ÂÆø‰∏ªÁªÜËÉûÂ¶ÇÊûúÂÜÖÂåñ‰∫ÜÈ´òPhoPQÊ¥ªÊÄßÁöÑÁªÜËèåÔºåÂàôÂëàÈ´òIÂûãÂπ≤Êâ∞Á¥†Â∫îÁ≠îÂèçÂ∫îÔºõËÄåÂÆø‰∏ªÁªÜËÉûÂ¶ÇÊûúÂÜÖÂåñ‰∫Ü‰ΩéPhoPQÊ¥ªÊÄßÁöÑÁªÜËèåÔºåÂàôÂëà‰ΩéIÂûãÂπ≤Êâ∞Á¥†Â∫îÁ≠îÂèçÂ∫î„ÄÇÁ†îÁ©∂ËØÅÊòé‰∫ÜÂÆø‰∏ªÁöÑÁªÜËÉûÁöÑÂÖçÁñ´Â∫îÁ≠îÂèçÂ∫îÂ∑ÆÂºÇÊòØÊù•Ê∫ê‰∫éÊÑüÊüìÁªÜËèåÁöÑËèåÁæ§Â∑ÆÂºÇÔºåËÄåÈùûÂÆø‰∏ªÁªÜËÉûÁöÑÁöÑÂºÇË¥®ÊÄß„ÄÇSalibaÁ≠â‰∫∫ÂàôÈÄöËøábulk dual-RNAseqÂèëÁé∞ÂÜÖÂåñÁöÑÂ¢ûÊÆñÂûãÂíåÈùûÂ¢ûÊÆñÂûãÊ≤ôÈó®Ê∞èËèåÂèØ‰ª•ÂºïËµ∑ÂÆø‰∏ªÂ∑®Âô¨ÁªÜËÉû‰∏çÂêåÁöÑË°®ÂûãÔºåÊúâÂà©‰∫éËá™Â∑±ÁöÑÁîüÂ≠ò„ÄÇ
ÊñáÁ´†‰ΩúËÄÖËÆ§‰∏∫ÁõÆÂâçÁ†îÁ©∂ËøõÂ±ïÊâÄÊè≠Á§∫ÁöÑÈóÆÈ¢òËøòÊØîËæÉÂàùÁ∫ßÔºå‰ªñÊèêÂá∫‰∫ÜÊõ¥Â§öÁöÑÁ†îÁ©∂ËÆÆÈ¢òÊúâÂæÖÊàë‰ª¨ÂéªÊåñÊéò„ÄÇËøô‰∫õÈÉΩÊòØÂÜôÂü∫ÈáëÂÜôÊú¨Â≠êÈùûÂ∏∏Â•ΩÁöÑ‰∏ªÈ¢òÔºåÁÆÄÁõ¥Â∞±ÊòØÂÜô‰ΩúÁöÑÊ∫êÊ≥âÔºåÊàëÁΩóÂàó‰∏Ä‰∏ã„ÄÇ
‰ªéÁªÜËèåÁöÑËßíÂ∫¶Ôºö‰∏∫‰ªÄ‰πàÁªÜËèåÈÄâÊã©ÊÄßÁöÑÊÑüÊüìÊüê‰∫õÁªÜËÉûÔºåËÄå‰∏çÊòØÊâÄÊúâÁöÑÁªÜËÉûÔºü‰∏∫‰ªÄ‰πàÁªÜËèåÂú®‰∏Ä‰∫õÁªÜËÉû‰∏≠Ë¢´Ê∏ÖÈô§ÔºåËÄåÂú®Âè¶‰∏Ä‰∫õ‰∏≠ËøõË°åÂ¢ûÊÆñÔºüÂØÑÁîüÁöÑÁªÜËèåÊòØÂ¶Ç‰ΩïË∞ÉÊéßÂÆø‰∏ªÁªÜËÉûÔºåÂ∏ÆÂä©ÂÆÉ‰ª¨ËøõË°åÊäóÁîüÁ¥†ÊäµÊäóÁöÑÔºü
‰ªéÂÆø‰∏ªÁªÜËÉûÁöÑËßíÂ∫¶ÔºöÂ¶Ç‰ΩïÈâ¥ÂÆöÊÑüÊüìÁöÑÁªÜËÉûÂíå‚ÄúÊóÅËßÇËÄÖ‚ÄùÔºüÂÆø‰∏ªÁªÜËÉûÁöÑÂ∫îÁ≠îÂ∑ÆÂºÇÊòØÁî±‰ªÄ‰πàÂØºËá¥ÁöÑÔºüÂ¶ÇÊûúÂÆø‰∏ªÁªÜËÉûÂ±àÊúçÔºåÊòØ‰ªÄ‰πàÂÜ≥ÂÆö‰∫ÜÁªÜËÉûÊ≠ª‰∫°ÁöÑÊ®°ÂºèÔºü
ÁóÖÊØí‰∏éÂÆø‰∏ªÂÖ≥Á≥ªÁöÑÁ†îÁ©∂ËøõÂ±ïÔºà‰∏æ‰æãÔºâ ÁóÖÊØíÊÑüÊüì‰∏éÁªÜËèåÊÑüÊüì‰∏çÂêåÔºåÁóÖÊØíÂú®ÊÑüÊüìÂâçÂíåÊÑüÊüìËøáÁ®ã‰∏≠ÔºåÂÖ∂ËΩ¨ÂΩïÊú¨‰∏çÂ≠òÂú®ÂºÇË¥®ÊÄß„ÄÇÂÆÉ‰ª¨ÁöÑÂºÇË¥®ÊÄßÂ≠òÂú®‰∫éÊ†∏ÈÖ∏Â∫èÂàóÂ±ÇÈù¢„ÄÇÂÆÉ‰ª¨ÂèØËÉΩÊù•Ê∫ê‰∫éÁóÖÊØí‰∫öÁæ§ÁöÑÊ†∏Ëã∑ÈÖ∏Â§öÊÄÅÊÄßÔºåvmRNAÔºàviral mRNAÔºâÁöÑÁ™ÅÂèòÔºåÁóÖÊØíÂü∫Âõ†ÁªÑÊã∑Ë¥ùÊï∞Â∑ÆÂºÇÁ≠â„ÄÇÊúâ‰∫õÁóÖÊØíÔºåÂ¶ÇÊµÅÊÑüÁóÖÊØíÔºåÂÆÉ‰ª¨ÁöÑvmRNA‰πüÊúâÂ∞æÈÉ®Âä†poly AÁöÑÁâπÂæÅÔºåÂæóÁõä‰∫éÊ≠§ÔºåÂ∏∏ËßÑÁöÑsc-RNAseqÊñπÊ≥ïÂèØ‰ª•ÂêåÊó∂ÊçïËé∑ÁóÖÊØíRNAÔºåÂíåÂÆø‰∏ªÁªÜËÉûmRNAÂÖ±ÂêåËøõË°åÂª∫Â∫ìÂíåÊµãÂ∫è„ÄÇÈÄöËøáÊØîÂØπÁóÖÊØívmRNAÂ∫èÂàóÔºåÂèØ‰ª•Èâ¥ÂÆöÂÆø‰∏ªÁªÜËÉûÁöÑÊÑüÊüìÁä∂ÊÄÅ„ÄÇÈÄöËøáUMIËÆ°ÁÆóvmRNAÁöÑ‰∏∞Â∫¶ÔºåÂèØ‰ª•Ëé∑ÂæóÂÆø‰∏ªÁªÜËÉûÁöÑÁóÖÊØíËΩΩÈáè‰ø°ÊÅØ„ÄÇ
SteuermanÁ≠â‰∫∫ÈÄöËøáÂØπÊÑüÊüìÊµÅÊÑüÁóÖÊØí2Â§©ÂêéÁöÑÂ∞èÈº†ËÇ∫ÁªÜËÉûËøõË°åÂçïÁªÜËÉûÊµãÂ∫èÔºåÈÄöËøáËÅöÁ±ªÂØπÁªÜËÉû‰∫öÁæ§ËøõË°åÂàÜÁ±ªÔºåÁªìÂêàÁªÜËÉû‰∏≠ÁöÑvmRNAÊ∞¥Âπ≥ÔºåËé∑ÂæóÁªÜËÉûÁöÑÁóÖÊØíËΩΩÈáè‰ø°ÊÅØÔºå‰ªñ‰ª¨ÂèëÁé∞Âá†‰πéÊâÄÊúâÁ±ªÂûãÁöÑÁªÜËÉû‰∏≠ÈÉΩÂèØ‰ª•Ê£ÄÊµãÂà∞vmRNAÔºåÊ∂µÁõñ‰∫Ü62%ÁöÑ‰∏äÁöÆÁªÜËÉûÂà∞22%ÁöÑTÁªÜËÉû„ÄÇËøô‰∏ÄÂèëÁé∞ÊåëÊàò‰∫Ü‰º†ÁªüÁöÑËÆ§Áü•ÔºåËÆ§‰∏∫ÊµÅÊÑüÁóÖÊØí‰∏ªË¶ÅÊÑüÊüì‰∏äÁöÆÁªÜËÉû„ÄÇËøôÂèØËÉΩÊòØÁî±‰∫é‰ª•ÂæÄÁ†îÁ©∂ÊòØÂà©Áî®ÁóÖÊØíË°®ËææÁöÑGFPÊä•ÂëäÂü∫Âõ†ÔºåÂú®ÂÖ∂‰ªñÁ±ªÂûãÁöÑÁªÜËÉû‰∏≠Èöæ‰ª•Ê£ÄÊµãÂà∞ÈÄ†ÊàêÁöÑ„ÄÇËøôÁØáÊñáÁ´†ÂêåÊó∂‰ªé‰æßÈù¢ËØÅÊòé‰∫ÜÂà©Áî®ÂçïÁªÜËÉûËøõË°åÁóÖÂéüËèåÁ†îÁ©∂ÁöÑÂøÖË¶ÅÊÄßÔºåÂçïÁªÜËÉûÊµãÂ∫èÁõ∏ÊØî‰º†ÁªüÊäÄÊúØËÉΩÊã•ÊúâÁöÑÊõ¥È´òÁöÑÁ≤æÂ∫¶„ÄÇÁ†îÁ©∂‰∫∫ÂëòËøòÂèëÁé∞Ôºå‰∏äÁöÆÁªÜËÉûÁöÑÁóÖÊØíËΩΩÈáèÂ∑ÆÂà´ËÉΩËææÂà∞2‰∏™Êï∞ÈáèÁ∫ßÔºåËÄåÂú®ÂÖ∂‰ªñÈùû‰∏äÁöÆÁªÜËÉû‰∏≠ÁóÖÊØíËΩΩÈáèÈÄöÂ∏∏Âæà‰Ωé„ÄÇ
Âè¶Â§ñ‰∏ÄÈ°πÁ†îÁ©∂‰∏≠ÔºåRussellÂà©Áî®‰ΩìÂ§ñÊÑüÊüìÊµÅÊÑüÁóÖÊØíÁöÑ‰∏äÁöÆÁªÜËÉûËøõË°åÂçïÁªÜËÉûÊµãÂ∫è„ÄÇ‰ΩìÂ§ñËØïÈ™åÂú®Âü∫Âõ†ÁªÑÊ∞¥Âπ≥‰∏äÈôêÂÆö‰∫ÜÊµÅÊÑüÁóÖÊØíÁöÑÂçïÂÖãÈöÜÊÄßÔºåÊúÄÂ§ßÈôêÂ∫¶ÁöÑÊéßÂà∂‰∫ÜÁóÖÊØíÂºÇË¥®ÊÄßÂØºËá¥ÁöÑÊ∑∑ÊùÇÂõ†Á¥†„ÄÇ‰ªñ‰ª¨‰ªçÁÑ∂ËßÇÂØüÂà∞vmRNAÂú®ÁªÜËÉû‰πãÈó¥ËΩΩÈáèÁöÑÂ∑®Â§ßÂ∑ÆÂºÇ„ÄÇÂ§ßÈÉ®ÂàÜÊÑüÊüìÁöÑÁªÜËÉû‰ªÖÊ£ÄÊµãÂà∞&lt;0.1% vmRNAÔºåËÄåÊúâ‰∫õÁªÜËÉû‰∏≠ËÉΩÊ£ÄÊµãÂà∞50%ÁöÑvmRNA„ÄÇ‰ªñ‰ª¨ÂèëÁé∞ÁóÖÊØíËΩΩÈáèÁöÑÂ∑ÆÂºÇ‰∏éÁóÖÊØíÁöÑÂü∫Âõ†Ë°®ËææÂíåÂÆø‰∏ªÊÑüÊüìÁõ∏ÂÖ≥ÁöÑÂü∫Âõ†Ë°®ËææÂπ∂‰∏çÁõ∏ÂÖ≥ÔºåËÄåÊòØÂíåÂÆø‰∏ªÊ∞ßÂåñÂ∫îÊøÄÔºåG2-MÁªÜËÉûÂë®ÊúüÁ≠âÂü∫Âõ†ÁöÑË°®ËææÁõ∏ÂÖ≥„ÄÇËøô‰∫õÁªìÊûúËÉåÂêéÁöÑÂéüÂõ†ÊúâÂæÖËøõ‰∏ÄÊ≠•Á†îÁ©∂„ÄÇ
‰ªéËøô‰∏§ÁØáÊñáÁ´†Âá∫ÂèëÔºå‰ΩúËÄÖÂèàÊèêÂá∫‰∫Ü‰∏Ä‰∫õÊúâÂæÖË¢´Ëß£Á≠îÁöÑÈóÆÈ¢ò„ÄÇÂêåÊ†∑ÔºåÂÆÉ‰ª¨‰πüÈÄÇÂêà‰Ωú‰∏∫Êú™Êù•Á†îÁ©∂ÁöÑ‰∏ªÈ¢ò„ÄÇ‰∏∫‰ªÄ‰πàÊúâÁöÑÁªÜËÉûÊúâÈ´òÁöÑÁóÖÊØívmRNAËΩΩÈáèÔºåËÄåÂÖ∂‰ªñÁªÜËÉûÂç¥‰ºº‰πéËÉΩÈôêÂà∂ÁóÖÊØíÂü∫Âõ†Ë°®ËææÔºüvmRNAÁöÑÂ∑ÆÂºÇÂØºËá¥‰∫Ü‰ªÄ‰πàÊ†∑ÁöÑÁîüÁâ©Â≠¶ÁªìÂ±ÄÔºüÁªÜËÉû‰∏≠ÁöÑÁóÖÊØíÂ§çÂà∂ÈáèÊòØÂê¶‰ªéÊï¥ÁêÜ‰∏äÂÜ≥ÂÆöÂÆø‰∏ªÁöÑÊÑüÊüìÁªìÂ±ÄÔºüÁªÜËÉûË£ÇËß£ÂíåÊΩú‰ºèÊÑüÊüì‰πãÈó¥ÁöÑËΩ¨ÂåñÊòØÂ¶Ç‰ΩïË∞ÉÊéßÁöÑÔºü
Á†îÁ©∂ÁóÖÂéü‰Ωì‰∏∫‰ªÄ‰πà(ÊúâÊó∂ÂÄô)Áî®‰∏ç‰∫ÜÂçïÁªÜËÉûÊµãÂ∫èÔºü Â∞ΩÁÆ°sc-RNAseqÊäÄÊúØÂèëÂ±ïËøÖÁåõÔºåËé∑Âæó‰∫ÜË∂äÊù•Ë∂äÂ§öÁöÑÂ∫îÁî®Âú∫ÊôØ„ÄÇÊØîÂ¶Ç‰∏ÄÁßçÂêç‰∏∫Nuc-seqÁöÑÊñπÊ≥ïÂèØ‰ª•ÂØπÂÜ∞ÂÜªÁªÑÁªáÊ†∑Êú¨ÁöÑÁªÜËÉûÊ†∏ËøõË°åÂàÜÁ¶ªÊ†áËÆ∞Ôºå‰ªéËÄåËß£Èô§‰∫ÜÂçïÁªÜËÉûÁ†îÁ©∂Âè™ËÉΩÂÅöÊñ∞È≤úÁªÑÁªáÁöÑÈôêÂà∂„ÄÇ‰∏ÄÁßçÂØπÁªÜËèåÂü∫Âõ†ÁªÑÂàÜÊûêÁöÑÊ∂≤Êª¥Ê≥ïÂæÆÊµÅÊéßÊäÄÊúØÔºåSiC-seqÔºå‰πüÊãìÂ±ïÂà∞ÁªÜËèåÂçïÁªÜËÉûËΩ¨ÂΩïÁªÑÁöÑÂ∫îÁî®È¢ÜÂüü„ÄÇÁÑ∂ËÄå‰ºº‰πéÊäÄÊúØÁöÑËøõÊ≠•ËøòÊ≤°ÊúâÊôÆÂèäÂà∞Á†îÁ©∂ÁóÖÂéü‰Ωì-ÂÆø‰∏ªÁõ∏‰∫í‰ΩúÁî®È¢ÜÂüü„ÄÇÊúÄÁêÜÊÉ≥ÁöÑÁ†îÁ©∂ÊñπÊ°àÊòØËÉΩÂ§üÂØπÈÖçÂØπÁöÑÂÆø‰∏ªÁªÜËÉûÂèäÂÖ∂ÂÜÖÂåñÁöÑÁóÖÂéü‰ΩìËøõË°åÂêåÊó∂ÊµãÂ∫èÔºàpaired dual sc-RNAseqÔºâÔºåÂ¶ÇÂõæcÊâÄÁ§∫„ÄÇ
ËøôÁßçÁêÜÊÉ≥ÊñπÊ°à‰∏çËÉΩÂÆûÁé∞ÁöÑÂéüÂõ†‰πã‰∏ÄÊù•Ëá™‰∫éÁóÖÂéü‰ΩìÔºàÂ∞§ÂÖ∂ÊòØÁªÜËèåÔºâÂú®ÂÆø‰∏ªÁªÜËÉû‰∏≠ÁöÑË°®Ëææ‰∏∞Â∫¶Â§™‰ΩéÔºåÂπ∂‰∏î‰∏éÂÆø‰∏ªÁªÜËÉûÁöÑmRNAÂê´ÈáèÂΩ¢ÊàêÂ∑®Â§ßÁöÑÊÇ¨ÊÆä„ÄÇÈÄöËøáÊîπËøõÂª∫Â∫ìÊñπÊ≥ïÔºåÁÆóÊ≥ïÊµÅÁ®ã‰ª•ÂèäÂ¢ûÂä†ÊµãÂ∫èÊ∑±Â∫¶ÂèñÂæó‰∫Ü‰∏Ä‰∫õËøõÂ±ï„ÄÇscDual-seqÊäÄÊúØÁöÑÂºÄÂèëËÄÖÂ£∞Áß∞Ôºå‰ªñ‰ª¨Âà©Áî®Âçï‰∏™ÁªÜËÉûÂíåÂçï‰∏™ËèåÁöÑÁ∫ØÂåñÁöÑRNAËøõË°åÂª∫Â∫ìÔºåËØ•ÊñπÊ≥ïËÉΩÂ§üÊµãÂ∫èÊ£ÄÊµãÂà∞470‰∏™Ê≤ôÈó®Ê∞èËèåÁöÑËΩ¨ÂΩïÊú¨ÔºåÊèêÁ§∫Â∞ΩÁÆ°Âü∫Âõ†Ë¶ÜÁõñÂ∫¶ËæÉ‰ΩéÔºå‰ΩÜÈíàÂØπÂçï‰∏™ÁªÜËèåÁöÑÊ£ÄÊµãÊòØÂèØË°åÁöÑ„ÄÇÊ≠§Â§ñ‰ªñ‰ª¨ÂØπÂÜÖÂåñ‰∫Ü1-10‰∏™Ê≤ôÈó®Ê∞èËèåÁöÑÁªÜËÉûËøõË°åÊµãÂ∫èÔºåËé∑ÂæóÁöÑËΩ¨ÂΩïÊú¨ÈáèÂíåÁªÜËèåÊï∞ÊòæÁ§∫Âá∫‰∫ÜÊØîËæÉÂ•ΩÁöÑÁ∫øÊÄßÂÖ≥Á≥ª„ÄÇ‰ΩÜÊòØËØ•ÊäÄÊúØËøòÊ≤°ÊúâÁªèËøá‰ΩìÂÜÖÂÆûÈ™åÈ™åËØÅ„ÄÇÂú®Ëá™ÁÑ∂Áä∂ÊÄÅ‰∏ãÔºåÁªùÂ§ßÂ§öÊï∞ÁöÑÁªÜËèåÊÑüÊüìÂëàÁé∞ÂÆø‰∏ªÁªÜËÉûÂíåÁªÜËèå1 vs 1ÁöÑÁä∂ÊÄÅ„ÄÇ‰Ωé‰∏∞Â∫¶ÁöÑÁªÜËèåËΩ¨ÂΩïÊú¨ÊòØÁõÆÂâçÊäÄÊúØÂèëÂ±ïÊúÄ‰∏ªË¶ÅÁöÑÊåëÊàò„ÄÇ
dual-sc-RNAseqÁöÑÂè¶‰∏ÄÈ°πÊåëÊàò‰πüÊòØÈíàÂØπÁªÜËèåÁöÑÔºåÂÆÉÁúã‰ººÂπ≥Âá°Ôºå‰ΩÜÈùûÂ∏∏Âõ∞Èöæ„ÄÇËøô‰∏ÄÂõ∞ÈöæÊå°Âú®‰∫ÜÊµãÂ∫èÊâÄÊúâÊµÅÁ®ãÁöÑÊúÄÂâçÈù¢‚Äî‚ÄîÁªÜËèåÊ†∏ÈÖ∏ÊèêÂèñÁöÑÂõ∞Èöæ„ÄÇÁî±‰∫éÂÖ∑ÊúâÂ§πÈ¶çÔºåÁªÜËÉûÂ£ÅÁ≠âÁªÜËÉûÁªìÊûÑÔºåÁªÜËèåÁöÑË£ÇËß£ÂèòÂæóÂõ∞Èöæ„ÄÇÁâ©ÁêÜË£ÇËß£Ê≥ïÁî±‰∫éÈúÄË¶ÅÊõ¥Â§ß‰ΩìÁßØÁöÑÊ∫∂ÂâÇÊó†Ê≥ïÈÖçÂ•óÂ∏∏ËßÑÁöÑÊ∂≤Êª¥Ê≥ïÊú∫Ê¢∞ÂàÜÈÄâÔºåÂåñÂ≠¶Ë£ÇËß£Ê≥ïÂàôÂÆπÊòìÂØºËá¥RNAÈôçËß£ÊàñËÄÖÊ±°ÊüìÔºå‰ªéËÄåÊó†Ê≥ïËøõË°åÂêéÁª≠ÁöÑÂª∫Â∫ìÂÆûÈ™å„ÄÇ
ÁóÖÂéü‰ΩìRNAÈáèÂíåÂÆø‰∏ªRNAÈáè‰πãÈó¥ÊÇ¨ÊÆäÁöÑÂ∑ÆÂºÇ‰πüÊòØdual sc-RNAseqÁöÑÊåëÊàò‰πã‰∏Ä„ÄÇ‰∏ãÂõæÁ§∫ÊÑèÁúüÊ†∏ÁªÜËÉûRNAÂíåÁªÜËèåRNAÁöÑ‰∏∞Â∫¶ÂÖ≥Á≥ª„ÄÇ‰∏Ä‰∏™Âì∫‰π≥Âä®Áâ©ÁªÜËÉûÂ§ßÁ∫¶Âê´Êúâ10pgÁöÑÊÄªRNAÔºåËÄåÂçï‰∏™ÁªÜËèåÂç¥Âè™Êúâ100fgÁöÑÊÄªRNAÔºåÁ∫¶‰∏∫Âì∫‰π≥Âä®Áâ©ÁöÑÁôæÂàÜ‰πã‰∏Ä„ÄÇÂõ†Ê≠§ÔºåÂú®‰∏Ä‰∏™ÂÆø‰∏ªÁªÜËÉûÊÑüÊüì‰∏Ä‰∏™ÁªÜËèåÁöÑÊÉÖÂÜµ‰∏ãÔºåÁªÜËèåÁöÑmRNAÂÆûÈôÖÂè™Âç†ÊÄªÊèêÂèñRNA‰∏≠ÁöÑÁ∫¶0.05%„ÄÇ‰∏æ‰∏™‰æãÂ≠êÔºåÁóÖÂéüËèå‰∏≠Ë°®ËææÈáèÊúÄÂ§ßÁöÑËΩ¨ÂΩïÊú¨ÔºåÂÖ∂Âê´ÈáèÂíåÂÆø‰∏ªÁªÜËÉû‰∏≠Ë°®ËææÈáèÊúÄÂ∞èÁöÑËΩ¨ÂΩïÊú¨Áõ∏ÂΩì„ÄÇÂõ†Ê≠§ÂèØÊÉ≥ËÄåÁü•ÔºåÊèêÈ´òÊñáÂ∫ìÊûÑÂª∫ÁöÑÊïàÁéáÔºåÊòØÊèêÈ´òÂü∫Âõ†Ë¶ÜÁõñÁéáÂíåÊ£ÄÊµãÁéáÁöÑÂÖ≥ÈîÆ„ÄÇÂêåÊó∂Êàë‰ª¨ÈúÄË¶ÅÊèêÈ´òÊ£ÄÊµãÊ†∑Êú¨ÁöÑÁªÜËÉûÊï∞Êù•Ëé∑ÂæóÂÖ∑ÊúâÁªüËÆ°Â≠¶ÊÑè‰πâÁöÑÁªìÊûú„ÄÇÂ∞ΩÁÆ°ÈÄöËøáËÆ°ÁÆóÊú∫Â∑•ÂÖ∑ÂíåÁÆóÊ≥ïËÉΩÊúâÊïàÈôç‰ΩéÂàÜÊûêÊâÄÈúÄÁöÑÁªÜËÉûÊï∞ÁõÆÔºå‰ΩÜËøôÈùûÂ∏∏‰æùËµñÊâÄÁªôÂÆöÁöÑÁóÖÂéüËèåÁöÑÂü∫Âõ†ÁªÑÊ≥®Èáä‰ø°ÊÅØÁöÑÂÆåÊï¥Á®ãÂ∫¶„ÄÇ Èô§‰∫ÜÂÆø‰∏ªÁªÜËÉûRNAÂØπÁóÖÂéü‰ΩìRNAÁöÑÁ®ÄÈáä‰ΩúÁî®ÔºåÁóÖÂéü‰ΩìmRNAÁöÑÊçïËé∑ËøòÂ≠òÂú®Âè¶‰∏ÄÈ°πÊåëÊàò„ÄÇÂíåÁúüÊ†∏ÁªÜËÉû‰∏ÄÊ†∑ÔºåÁªÜËèåmRNA‰πüÂè™Âç†ÂÖ∂ÊÄªRNAÁöÑ5-10%„ÄÇÂØπ‰∫éÁúüÊ†∏ÁªÜËÉûÔºåÂÖ∂mRNAÂÖ∑Êúâploy AÂ∞æÁöÑÁâπÂæÅÔºåÂõ†Ê≠§ÈÄöËøá‰∫íË°•ÁöÑpoly TÂºïÁâ©ÂèØ‰ª•ÂæàÂ•ΩÁöÑÂØπÂÖ∂ËøõË°åÂØåÈõÜÂíåÊçïËé∑„ÄÇËÄå**ÂéüÊ†∏ÁªÜËÉûÔºàÁªÜËèåÔºâÁöÑmRNAÂπ∂Ê≤°Êúâpoly AÂ∞æ„ÄÇ**Âõ†Ê≠§Â∏∏ËßÑÂª∫Â∫ìÊó†ÂèØÈÅøÂÖçÁöÑ‰ºöÂºïÂÖ•Â§ßÈáèÁöÑrRNAÂíåtRNA„ÄÇËøô‰∏™ÈöæÈ¢òÂèØ‰ª•ÈÄöËøáÂä†Â§ßÊµãÂ∫èÊ∑±Â∫¶ÔºåÂèçÂêëÂéªÈô§rRNAÊàñËÄÖÂà©Áî®Êé¢ÈíàÊ≠£ÂêëÊçïËé∑ÁóÖÂéü‰ΩìmRNAÊù•Ëß£ÂÜ≥„ÄÇ
ÂíåÁªÜËèå‰∏çÂêåÔºåÊúâ‰∫õÁóÖÊØíÁöÑvmRNAÂÖ∑Êúâpoly AÂ∞æÁöÑÁâπÂæÅÔºåÂ¶ÇÁôªÈù©ÁÉ≠ÁóÖÊØíÔºåË•øÂ∞ºÁΩóÊ≤≥ÁóÖÊØíÂíå‰∏ôÂûãËÇùÁÇéÁóÖÊØí„ÄÇÂõ†Ê≠§Âú®Á†îÁ©∂ÂÆÉ‰ª¨ÂíåÂÆø‰∏ª‰πãÈó¥ÁöÑÂÖ≥Á≥ªÊó∂ÔºåÂ∞±Êúâ‰∫ÜÂæóÂ§©Áã¨ÂéöÁöÑ‰ºòÂäø„ÄÇ‰ΩÜÊòØÔºåËøô‰∏™ÁâπÁÇπÂπ∂‰∏çË¶ÜÁõñÊâÄÊúâÁöÑÁóÖÊØíÁßçÁ±ª„ÄÇÈô§Ê≠§‰πãÂ§ñÔºåÁ†îÁ©∂ÂèëÁé∞ÁóÖÊØíÁöÑÂü∫Âõ†ÁªÑ‰ºöÂá∫Áé∞Á±ª‰ºº‰∫éÂçïÊ†∏Ëã∑ÈÖ∏Â§öÊÄÅÊÄßÁöÑÁ™ÅÂèòÔºåËÄåËøôÁßçÂæÆÂ∞èÁöÑÂèòÂºÇ‰ºöÂΩ±ÂìçÂÆø‰∏ªÁöÑÂ∫îÁ≠î„ÄÇÂõ†Ê≠§Âú®Á†îÁ©∂ÁóÖÊØíÊó∂ÈúÄË¶ÅÊúâÊõ¥Â•ΩÁöÑËÆ°ÁÆóÂ∑•ÂÖ∑ËÉΩÂ§üÂú®ÂçïÁªÜËÉûÊ∞¥Âπ≥ÂéªÂàÜÊûêÁóÖÊØíÂü∫Âõ†ÁªÑÂ§öÊ†∑ÊÄß‰∏éÂÆø‰∏ªÂ∫îÁ≠î‰πãÈó¥ÁöÑÂÖ≥Á≥ª„ÄÇ
ÊÄªÁªì ÂçïÁªÜËÉûRNAseqÈù©ÂëΩÊãìÂÆΩ‰∫ÜÊàë‰ª¨ÂØπÁªÜËÉûÂºÇË¥®ÊÄßÁöÑÁêÜËß£ÔºåÂπ∂‰∏îËÆ§ËØÜÂà∞Á®ÄÊúâÁªÜËÉûÁ±ªÂûãÂú®ÊâÄÊúâÁîüÁâ©Â≠¶È¢ÜÂüüÔºàÂåÖÊã¨ÂÆø‰∏ª- ÁóÖÂéü‰ΩìÁõ∏‰∫í‰ΩúÁî®ÔºâÁöÑÂ≠òÂú®ÂíåÈáçË¶ÅÊÄß„ÄÇ ËøôÁØáÁªºËø∞Âº∫Ë∞É‰∫ÜÂÆø‰∏ªÂíåÁóÖÂéü‰ΩìÂêÑËá™ÁöÑÂºÇË¥®ÊÄßÂØºËá¥‰∫Ü‰ªñ‰ª¨ÈÅ≠ÈÅáÂêéÁöÑÊó†Êï∞ÂèØËÉΩÁöÑÁªìÊûú„ÄÇ ÂçïÁªÜËÉûËßÜËßíÁ†îÁ©∂ÁªÜËÉûË°å‰∏∫Â∞ÜÊòØÊàë‰ª¨Á†îÁ©∂Â§çÊùÇÁîüÁêÜÂíåÁóÖÁêÜÁä∂ÊÄÅ‰∏ãÁöÑÁîüÁâ©Â≠¶Áé∞Ë±°Êú™Êù•‰∏ªË¶ÅÁöÑÁ†îÁ©∂ÊâãÊÆµ„ÄÇ]]></description>
</item>
<item>
    <title>„Äêbioinfo„Äë-Q&amp;A-56</title>
    <link>https://uioqps.github.io/bioinfo-q-a-56/</link>
    <pubDate>Fri, 21 Feb 2020 22:02:55 &#43;0000</pubDate>
    <author>Milky</author>
    <guid>https://uioqps.github.io/bioinfo-q-a-56/</guid>
    <description><![CDATA[Â§öÊó∂Èó¥ÁÇπÂèñÊ†∑ËΩ¨ÂΩïÁªÑÊï∞ÊçÆ Êó∂Èó¥Â∫èÂàóË°®ËææÁü©ÈòµÊè≠Á§∫ËÇøÁò§ËΩ¨ÁßªÁöÑÂä®ÊÄÅËøáÁ®ã ËÇùÁôåÂæàÂèØÊÄïÔºåÂ∞§ÂÖ∂ÊòØËΩ¨ÁßªÂêéÔºåÂæàÂ§öÂÖ≥‰∫éÂÖ∂ËΩ¨ÁßªÂâçÂêéÂØπÊØîÁöÑÁ†îÁ©∂Ôºå‰ΩÜÊòØÁº∫‰πè‰∏≠Èó¥ËøáÁ®ãÊï∞ÊçÆÔºåÁâπÂà´ÊòØËΩ¨Áßª‰∏¥ÁïåÁÇπ„ÄÇ
‰ΩúËÄÖÈÄöËøáËÇùÁôåÊ®°ÂûãÔºåÂú®‰∏çÂêåÊó∂Èó¥ÁÇπÂèñÊ†∑ÂÅöËäØÁâáËΩ¨ÂΩïÁªÑÔºåËØïÂõæÂàÜÊûê non-metastatic (or normal) and pre-metastatic (or critical) Ëøô‰∏§ÁßçÁä∂ÊÄÅÂå∫Âà´„ÄÇÈ°∫Âà©ÊâæÂà∞‰∫Ü‰∏¥ÁïåÁÇπÂèäÂÖ∂Áõ∏ÂÖ≥Ë∞ÉÊéßÁΩëÁªúÔºåËÄå‰∏îËøòÈáçÁÇπÂàÜÊûê‰∫ÜÂÖ∂‰∏≠‰∏Ä‰∏™ÁΩëÁªúÁöÑÊúÄÈáçË¶ÅÁöÑËäÇÁÇπÂü∫Âõ†ÔºöCALML3
To discover early warning signals of pulmonary metastasis in HCC, we analysed time-series gene expression data in the spontaneous pulmonary metastasis mouse HCCLM3-RFP model with our novel dynamic network biomarker (DNB) method.
ÊûÑÂª∫‰∫Ü xenograft HCCLM3-RFP mice Ôºå 20Âè™Â∞èÈº†ÂàÜÊàê4ÁªÑÔºåÂç≥4‰∏™Êó∂Èó¥ÁÇπ(W2, W3, W4, W5)ÂèñÊ†∑„ÄÇ
ÊâæÂ∑ÆÂºÇÂü∫Âõ† ‰ΩøÁî®ÁöÑÊòØ‰º†ÁªüÁöÑTÊ£ÄÈ™åÔºåÂØπ‰ªªÊÑè‰∏§ÁªÑÁöÑÁªÑÂêàÊâæÂ∑ÆÂºÇÔºåÊúÄÂêéÂêàÂπ∂Êàê13,247 ‰∏™Â∑ÆÂºÇÂü∫Âõ†ÂàóË°®ÔºåÂπ∂‰∏îÁªòÂà∂ÁÉ≠ÂõæÂ¶Ç‰∏ãÔºö
Êó∂Èó¥Â∫èÂàóÂü∫Âõ†ÈõÜ ‰ΩøÁî®ÁöÑÊòØRÂåÖMfuzzÊääÂ∑ÆÂºÇÂàÜÊûêÂæóÂà∞ÁöÑ13,247 ‰∏™ÁªüËÆ°Â≠¶ÊòæËëóÂ∑ÆÂºÇÂü∫Âõ†Ê†πÊçÆË°®ËææÊ®°ÂºèÂàÜÊàê‰∫Ü6ÁªÑÔºåÂ¶Ç‰∏ãÔºö
Ëøô6ÁªÑÂü∫Âõ†ÈõÜÁâπÊÄßÊòØÔºö
 Genes in Clusters 1 and 2 were continuously and monotonically downregulated and upregulated from the second to fourth weeks after orthotropic implantation, respectively.]]></description>
</item>
<item>
    <title>„Äêbioinfo„Äë-Q&amp;A-52</title>
    <link>https://uioqps.github.io/bioinfo-q-a-52/</link>
    <pubDate>Fri, 21 Feb 2020 22:02:41 &#43;0000</pubDate>
    <author>Milky</author>
    <guid>https://uioqps.github.io/bioinfo-q-a-52/</guid>
    <description><![CDATA[PDAC-organoids ËÉ∞ËÖ∫ÁôåÁöÑÁ±ªÂô®ÂÆòÂèØ‰ª•ËæÖ‰ΩêÊ≤ªÁñóÂÜ≥Á≠ñ PDACËÉåÊôØÁü•ËØÜ ËÉ∞ËÖ∫ÁôåÁîüÈïøÂø´ËÄå‰∏îËΩ¨ÁßªÁéáÈ´òÔºåÊòØ‰∏ÄÁßçÈùûÂ∏∏Ëá¥ÂëΩÁöÑÊÅ∂ÊÄßÁñæÁóÖ„ÄÇ2016Âπ¥ÁæéÂõΩÁôåÁóáÂçè‰ºöÁöÑÊï∞ÊçÆÊòæÁ§∫ÔºåËÉ∞ËÖ∫ÁôåÊÇ£ËÄÖÁöÑ5Âπ¥ÁîüÂ≠òÁéáÂú®7-8%‰πãÈó¥„ÄÇËôΩÁÑ∂ÊâãÊúØÂèØ‰ª•Ê†πÊ≤ªËøôÁßçÁñæÁóÖÔºå‰ΩÜËÉ∞ËÖ∫ÁôåÂú®Á°ÆËØäÊó∂Âè™Êúâ10‚Äì20%ÊòØÂèØÂàáÈô§ÁöÑÔºåÂÖ∂ÂÆÉÊÇ£ËÄÖÂè™ËÉΩÊé•ÂèóÂåñÁñó„ÄÇ
2Êúà8Êó•Âú®Nature Communications‰∏äÂèëË°®ÁöÑGWASÁ†îÁ©∂Á∫≥ÂÖ•‰∫Ü21,536‰∫∫ÔºåÂèëÁé∞‰Ωç‰∫é‰∫∫Á±ªÊüìËâ≤‰Ωì1Ôºà‰ΩçÁΩÆ1p36.33Ôºâ„ÄÅ7Ôºà‰ΩçÁΩÆ7p12Ôºâ„ÄÅ8Ôºà‰ΩçÁΩÆ8q21.11Ôºâ„ÄÅ17Ôºà‰ΩçÁΩÆ17q12ÔºâÂíå18Ôºà‰ΩçÁΩÆ18q21.32Ôºâ‰∏äÁöÑÊñ∞Èâ¥ÂÆöÁöÑÈÅó‰º†ÂèòÂºÇÂèØÂ¢ûÂä†ËÉ∞ËÖ∫ÁôåÈ£éÈô©„ÄÇËøô‰∫õÂü∫Âõ†ÁªÑ‰∏≠ÊØè‰∏™Êã∑Ë¥ùÁöÑÂ≠òÂú®ÈÉΩ‰ºöÂ¢ûÂä†ËÉ∞ËÖ∫ÁôåÈ£éÈô©15ÔºÖ-25ÔºÖ„ÄÇ
ÂÖ≥‰∫éËÉ∞ËÖ∫ÁôåÂèëÁîüÁöÑÁºòËµ∑ÂÅáËØ¥ÁõÆÂâç‰∏ªË¶ÅÈõÜ‰∏≠Âú®‰∏§‰∏™Â≠¶ËØ¥Ôºå‰∏Ä‰∏™ÊòØÊúÄÊó©Áî±ËÇøÁò§ÈÅó‰º†Â≠¶‰º†Â•á‰∫∫Áâ©Alfred G KnudsonÊèêÂá∫ÁöÑËÇøÁò§ÁöÑ‚Äú‰∫åÊ¨°ÊâìÂáªÂ≠¶ËØ¥‚ÄùÔºåÂÖ∂ÂêéÁî±ËØ∏Â§öËÉ∞ËÖ∫ÁôåÁ†îÁ©∂È¢ÜÂüüÁöÑÁßëÂ≠¶ÂÆ∂ÂÆåÂñÑÂπ∂Á°ÆÂÆöÊèêÂá∫ÁöÑ‚ÄúKras-CDKN2A-P53-SMAD4‚ÄùÊàêÊ¨°Â∫èÊîπÂèòÂíåÈÄêÊ≠•ÁßØÁ¥ØÁöÑÊèèËø∞ËÉ∞ËÖ∫ËÇøÁò§Áî±PanINsÂèëÂ±ïËá≥PDACÁöÑÂ≠¶ËØ¥‰ΩìÁ≥ª„ÄÇËá™Ê≠§ÔºåÂè§ËÄÅÁöÑÂü∫‰∫éÁóÖÁêÜÂΩ¢ÊÄÅÁöÑÂ≠¶Áßë‰ΩìÁ≥ª‰∏éÊñ∞ÂûãÁöÑÂü∫‰∫éÂü∫Âõ†ÂàÜÂ≠êÁîüÁâ©ÂàÜÂûãÁöÑÂ≠¶Áßë‰ΩìÁ≥ªÂèòÂæó‰∏çÂÜçÂêÑËá™Â≠§Á´ãÔºöËøë20Âπ¥Èó¥ÁöÑÁ≥ªÂàóÁ†îÁ©∂Âú®ËÉ∞ËÖ∫Áôå‰∏≠ÊØîËæÉÊúâ‰ª£Ë°®ÊÄßÂú∞Âº∫Ë∞É‰∫ÜËÉ∞ËÖ∫ÁôåÁóÖÁêÜÂΩ¢ÊÄÅÊîπÂèòÂíåÂàÜÂ≠êÁîüÁâ©Â≠¶ÊîπÂèòÁöÑÂπ≥Ë°åÁõ∏ÂÖ≥ÊÄß„ÄÇËÄå2017Âπ¥ÁöÑ‰∏ÄÈ°πÊù•Ëá™dana farberÂíåÂìàÂºóÂåªÂ≠¶Èô¢ÁöÑÊúÄÊñ∞Á†îÁ©∂Êõ¥ÊòØÂú®356‰æãËÉ∞ËÖ∫ÁôåÊ†∑Êú¨‰∏≠ËæÉ‰∏∫ÂÖ®Èù¢ÂíåÂÆåÊï¥Âú∞ÁöÑÊé¢Á¥¢Âõõ‰∏™ÂÖ≥ÈîÆÈ©±Âä®Âü∫Âõ†ÊîπÂèò‰∏éËÉ∞ËÖ∫ÁôåÈ¢ÑÂêéÁöÑÁõ∏ÂÖ≥ÊÄßÔºàÂõõÂ§ßÈ©±Âä®Âü∫Âõ†‰∏≠ÔºåKRASÂíåCDKN2A‰∏é‰∏¥Â∫äÈ¢ÑÂêéÁ¥ßÂØÜÁõ∏ÂÖ≥Ôºõ‰∏éÊ≠§ÂêåÊó∂ÔºåÈ©±Âä®Âü∫Âõ†ÁöÑÁ™ÅÂèò‰∏™Êï∞Ë∂äÂ§öÔºåÈ¢ÑÂêéË∂äÂ∑ÆÔºâ
TCGAÊï∞ÊçÆÂàÜÊûêPDACÂàÜÊàê‰∏§‰∏™Â§ßÁ±ªÔºö
 The Basal-like, Squamous or Quasi-mesenchymal, subtype identifies PDAC patients with poor prognosis and is characterized by basal markers such as cytokeratins. The Classical or Pancreatic Progenitor subtype is characterized by differentiated ductal markers and identifies patients with a better prognosis.  ÂÆûÈ™åËÆæËÆ° Êú¨Á†îÁ©∂ÊòØ‰ªéPDACÁóÖ‰∫∫ÁöÑËÇøÁò§ÈÉ®ÂàÜÂèñÊ†∑ÂÅö3DÂüπÂÖªÔºö
ÊÄªÂÖ±ÊòØ138‰∏™ÁóÖ‰∫∫ÔºåÈáåÈù¢Âèñ‰∫Ü 159‰∏™Ê†∑ÂìÅÔºåÂåÖÊã¨ primary tumors (hT) metastases (hM)
 78 ‰∏™Ê†∑Êú¨ÊòØspecimens were isolated from surgical resections 60 ‰∏™Ê†∑Êú¨ÊòØfine needle biopsies of primary or metastatic lesions (hF) 20‰∏™Ê†∑Êú¨ÊòØ metastatic disease following rapid autopsies 1‰∏™Ê†∑Êú¨ÊòØa video-assisted thoracoscopic surgical (VATS) resection of a lung metastasis.]]></description>
</item>
<item>
    <title>„Äêbioinfo„Äë-Q&amp;A-50</title>
    <link>https://uioqps.github.io/bioinfo-q-a-50/</link>
    <pubDate>Thu, 20 Feb 2020 19:42:50 &#43;0000</pubDate>
    <author>Milky</author>
    <guid>https://uioqps.github.io/bioinfo-q-a-50/</guid>
    <description><![CDATA[ÂçïÁªÜËÉûËΩ¨ÂΩïÁªÑÊé¢Á¥¢CRCÁóÖ‰∫∫ÁöÑ‰∏ÄËá¥ÊÄß  Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors. Nat Genet 2017 May;49(5):708-718. PMID: 28319088
 ÂçïÁªÜËÉûËΩ¨ÂΩïÁªÑÔºå‰ΩøÁî®ÁöÑÊòØGPL11154Illumina HiSeq 2000 (Homo sapiens) ÔºåÊï∞ÊçÆÈÉΩ‰∏ä‰º†Âà∞‰∫ÜÔºöGSE81861 ÔºõBioProjectÔºöPRJNA323703ÔºõSRAÔºöERP016958
Êó¢ÊúâÁóÖ‰∫∫ÁöÑÂçïÁªÜËÉûËΩ¨ÂΩïÁªÑÊï∞ÊçÆÔºåÂêåÊó∂‰πüÊúâÁªÜËÉûÁ≥ªÁöÑÊï∞ÊçÆÂÅöÈ™åËØÅ„ÄÇ
 1,591 single cells from 11 colorectal cancer patientsÔºåÂåÖÊã¨ 969ËÇøÁò§ÈÉ®‰ΩçÁªÜËÉû‰ª•Âèä 622 ÁôåÊóÅÁªÜËÉû„ÄÇ‰∏•Ê†ºËøáÊª§ÂêéÂè™Ââ©‰∏ãÔºö375 tumor cells and 215 normal mucosa cells -630 single cells from 7 cell linesÔºåËøáÊª§ÂêéÂâ©‰∏ã561‰∏™ 83 A549 cells, 65 H1437 cells, 55 HCT116 cells, 23 IMR90 cells, 96 K562 cells, 134 GM12878 cells (38 from batch 1, 96 from batch 2) 174 H1 cells (96 from batch 1, 78 from batch 2).]]></description>
</item>
<item>
    <title>„Äêbioinfo„Äë-Q&amp;A-48</title>
    <link>https://uioqps.github.io/bioinfo-q-a-48/</link>
    <pubDate>Thu, 20 Feb 2020 19:42:43 &#43;0000</pubDate>
    <author>Milky</author>
    <guid>https://uioqps.github.io/bioinfo-q-a-48/</guid>
    <description><![CDATA[PRCÂ§çÂêàÁâ©ÊäëÂà∂/ÊøÄÊ¥ªÁöÑÂü∫Âõ†Âπ≤Êâ∞‰∫ÜÂçïÁªÜËÉûÁöÑÂü∫Âõ†Ë°®Ëææ  Flipping between Polycomb repressed and active transcriptional states introduces noise in gene expression
 ËÉåÊôØÁü•ËØÜ Polycomb repressive complexes (PRCs) ÊòØÈùûÂ∏∏ËëóÂêçÁöÑÁªÑËõãÁôΩ‰øÆÈ•∞Â§çÂêàÁâ©Ôºå‰∏ÄËà¨Êù•ËØ¥ÊòØÊäëÂà∂Âü∫Âõ†Ë°®ËææÁöÑ„ÄÇ‰ΩÜÊòØÂ¶ÇÊûúÊüêÂü∫Âõ†ÂêåÊó∂Ë¢´PRCÂ§çÂêàÁâ©ÂíåRNA polymerase II (RNAPII)ÁªìÂêàÔºå‰πüÂèØ‰ª•Ë¢´ÊøÄÊ¥ªËΩ¨ÂΩï„ÄÇ‰ΩÜÂÖ∂‰∏≠Êú∫ÁêÜ‰∏çÊòé„ÄÇ
 PRC1, which monoubiquitinylates histone 2‚ÄâA lysine 119 (H2Aub1) via the ubiquitin ligase RING1A/B; PRC2, which catalyzes dimethylation and trimethylation of H3K27 (H3K27me2/3) via the histone methyltransferase (HMT) EZH1/2.  Embryonic stem cells (ESCs) ËÉΩËá™ÊàëÊõ¥Êñ∞Âπ∂‰∏îÂÖ∑ÊúâÂàÜÂåñÊàêÂÖ∂ÂÆÉÁªÜËÉûÁ±ªÂûãÁöÑÊΩúÂäõÔºåÂπ∂‰∏îËÆ§‰∏∫ÂÖ∂Âπ≤ÁªÜËÉûÁâπÊÄßÁî±Ë°®ËßÇË∞ÉÊéß‰øùÊåÅ„ÄÇ‰∏ÄËà¨ÁªèÁî±Âπ≤ÁªÜËÉûmarkerÊåëÈÄâÔºåÊØîÂ¶ÇOct4ÔºåÈúÄË¶ÅÂæàÊòéÁ°ÆÁöÑËØÅÊòéÂÖ∂‰∏çË°®ËææÂàÜÂåñmarkerÔºåÊØîÂ¶ÇGata4 and Gata6„ÄÇÂèØ‰ª•ÂØπËøô‰∏§‰∏™markerÂü∫Âõ†ÈõÜÂêàÂÅöÁÉ≠ÂõæÔºåÂ¶Ç‰∏ãÔºö
RNAPIIÁöÑ‰øÆÈ•∞ÂÜ≥ÂÆöÁùÄËΩ¨ÂΩïËøáÁ®ãÔºå‰∏ªË¶ÅÊòØÂÖ∂Á¢≥Êú´Á´ØÁöÑÁ£∑ÈÖ∏Âåñ‰øÆÈ•∞„ÄÇÂÖ∑‰ΩìÂ∑≤Áü•ÁªìËÆ∫Â¶Ç‰∏ãÔºö
1 2 3 4  Phosphorylation of S5 residues (S5p) correlates with initiation, capping, and H3K4 HMT recruitment.]]></description>
</item>
<item>
    <title>„Äêbioinfo„Äë-Q&amp;A-47</title>
    <link>https://uioqps.github.io/bioinfo-q-a-47/</link>
    <pubDate>Thu, 20 Feb 2020 19:42:40 &#43;0000</pubDate>
    <author>Milky</author>
    <guid>https://uioqps.github.io/bioinfo-q-a-47/</guid>
    <description><![CDATA[ÂçïÁªÜËÉûËΩ¨ÂΩïÁªÑÊé¢Á¥¢Â§¥È¢àÁôåÁóáÁöÑËΩ¨ÁßªÁôåÂíåÂéü‰ΩçÁôåÂå∫Âà´ Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer ÊµãÂ∫èÂ¶Ç‰∏ãÔºõ
 We profiled transcriptomes of ‚àº6,000 single cells from 18 head and neck squamous cell carcinoma (HNSCC) patients, including five matched pairs of primary tumors and lymph node metastases.
 ÂêåÊó∂‰πüÂØπËøô‰∫õÁóÖ‰∫∫Êµã‰∫Üwhole-exome sequencing (WES) and targeted genotyping (SNaPshot) dataÔºå‰ΩÜÊòØËøô‰∫õÊï∞ÊçÆÂÖ¨Â∏ÉÂú® phs001474.v1.p1 Ôºå‰∏çÊòØÂæàÊñπ‰æø‰∏ãËΩΩ„ÄÇ
ÂçïÁªÜËÉûËΩ¨ÂΩïÁªÑÂª∫Â∫ìÁî®ÁöÑSmart-seq2ÊñπÊ≥ïÔºåÊâÄÊúâÁöÑÊï∞ÊçÆÂÖ¨Â∏ÉÂú® GSE103322 Ôºå ‰ªÖ‰ªÖÊòØË°®ËææÁü©ÈòµÈÉΩÊúâËøë100Mb‰∫Ü„ÄÇ
ÂÆûÈ™åÈ™åËØÅÁî®ÁöÑÊòØÁªÜËÉûÁ≥ª Oral cavity HNSCC cell lines (Cal-27, SCC9, SCC4, SCC25, and JHU-006; all derived from male patients) ÂÅö‰∫ÜRNA-seq Êï∞ÊçÆ„ÄÇ]]></description>
</item>
<item>
    <title>„Äêbioinfo„Äë-Q&amp;A-46</title>
    <link>https://uioqps.github.io/bioinfo-q-a-46/</link>
    <pubDate>Thu, 20 Feb 2020 19:42:36 &#43;0000</pubDate>
    <author>Milky</author>
    <guid>https://uioqps.github.io/bioinfo-q-a-46/</guid>
    <description><![CDATA[Êó∂Èó¥Â∫èÂàóÂçïÁªÜËÉûËΩ¨ÂΩïÁªÑÊï∞ÊçÆÂàÜÊûê  Reconstruction of developmental landscapes by optimal-transport analysis of single-cell gene expression sheds light on cellular reprogramming. ÂåÖÂê´‰∫ÜÂÖ≠‰∏áÂ§ö‰∏™ÂçïÁªÜËÉûËΩ¨ÂΩïÁªÑÊï∞ÊçÆÔºåÊåÅÁª≠ËøΩË∏™‰∫ÜMEFÁªÜËÉûÁ≥ªËØ±ÂØº‰∏∫IPSCÁªÜËÉûÁöÑÂä®ÊÄÅÂèòÂåñËøáÁ®ãÔºåÂπ∂‰∏î‰ªéÂèëËÇ≤ÁöÑËßíÂ∫¶ÂàÜÊûê‰∫ÜËøô‰∫õÊï∞ÊçÆ
  We demonstrate the power of WADDINGTON-OT by applying the approach to study 65,781 scRNA-seq profiles collected at 10 time points over 16 days during reprogramming of fibroblasts to iPSCs.
 ËÉåÊôØ‰ªãÁªç WaddingtonÊèêÂá∫ÁöÑÂèëËÇ≤ÊôØËßÇ ‰∏ä‰∏ñÁ∫™50Âπ¥‰ª£ÔºåËÉöËÉéÂèëËÇ≤ÁîüÁâ©Â≠¶ÂÆ∂Conrad Hal WaddingtonÊèêÂá∫ÁöÑÂèëËÇ≤ÊôØËßÇÂÅáËØ¥ËÆ§‰∏∫ÔºåÂàÜÂåñÊàêÁÜüÁöÑÁªÜËÉûÂèòÂõûÂ§öËÉΩÂπ≤ÁªÜËÉûÊòØ‰∏™‰∏çÂèØËÉΩÂèëÁîüÁöÑ‰∫ã‰ª∂„ÄÇ‰ΩÜÊòØÊó•Êú¨‰∫¨ÈÉΩÂ§ßÂ≠¶ÊïôÊéàÂ±±‰∏≠‰º∏Âº•‰∫é2006Âπ¥Âç¥ÂèëÁé∞Âπ∂È™åËØÅÔºåËøôÁßçÁªÜËÉûÂèØ‰ª•ÂèëËÇ≤Êàê‰∏∫Ë∫´‰ΩìÂêÑÁßçÁªÑÁªáÁªÜËÉû„ÄÇiPSÁªÜËÉûÁöÑÂèëÁé∞ÊàêÂ∞±‰∫ÜÁõÆÂâçËΩ∞ËΩ∞ÁÉàÁÉàÁöÑÂπ≤ÁªÜËÉûÁ†îÁ©∂È¢ÜÂüüÔºåÂ±±‰∏≠‰º∏Âº•ÊïôÊéà‰πüÂõ†Ê≠§Ëé∑Âæó2012Âπ¥ËØ∫Ë¥ùÂ∞îÁîüÁêÜÊàñÂåªÂ≠¶Â•ñ„ÄÇ
iPS (ËØ±ÂØºÂ§öÊΩúËÉΩÂπ≤ÁªÜËÉû)ÈáçÁºñÁ®ãÂÆûÈ™åÁöÑÊ∂åÁé∞‰Ωø‰∫∫‰ª¨ÈáçÊñ∞ÈáçËßÜ‰∫Ü‰∏ä‰∏™‰∏ñÁ∫™50Âπ¥‰ª£ËÉöËÉéÂèëËÇ≤ÁîüÁâ©Â≠¶ÂÆ∂WaddingtonÊèêÂá∫ÁöÑÂèëËÇ≤ÊôØËßÇ„ÄÇËôΩÁÑ∂ÂÆÉÂè™ÊòØ‰∏Ä‰∏™ÈöêÂñª,‰ΩÜÂÖ∂ÂΩ¢Ë±°Âú∞ÊèèËø∞‰∫ÜÁªÜËÉûÁöÑËá™ÂèëÁöÑÂ±ÇÊ¨°ÂàÜÂèâËøáÁ®ãÂπ∂ÈöêÂê´‰∫ÜÁªÜËÉûÁ±ªÂûã‰πãÈó¥ËΩ¨Êç¢ÁöÑÂèØËÉΩÊÄß,‰ªéËÄå‰Ωú‰∏∫‰∏Ä‰∏™Êï¥‰ΩìÊ°ÜÊû∂ÊúÄËøëË¢´ÂπøÊ≥õÂ∫îÁî®Êù•Ëß£ÈáäÁªÜËÉûÂèëËÇ≤ÂíåÈáçÁºñÁ®ã„ÄÇ
ËØ¶ËßÅÔºöhttps://zhuanlan.zhihu.com/p/25333058
Waddington Âú®‰∏§‰∏™Êó∂ÊúüÊèêÂá∫ÁöÑÂÅáËØ¥Ôºö
 initially (1936) illustrated by railroad cars on switching tracks (A) later (1957) by marbles rolling in a landscape (B), with trajectories shaped by hills and valleys.]]></description>
</item>
<item>
    <title>„Äêbioinfo„Äë-Q&amp;A-42</title>
    <link>https://uioqps.github.io/bioinfo-q-a-42/</link>
    <pubDate>Thu, 20 Feb 2020 19:42:22 &#43;0000</pubDate>
    <author>Milky</author>
    <guid>https://uioqps.github.io/bioinfo-q-a-42/</guid>
    <description><![CDATA[Áî®Á±≥Ê∞èÊñπÁ®ãËß£ÂÜ≥ÂçïÁªÜËÉûËΩ¨ÂΩïÁªÑdropoutÁé∞Ë±°  Á±≥Ê∞èÊñπÁ®ãÔºàMichaelis-Menten equationÔºâ: v=Vmax √ó [S] /ÔºàKm+[S]) Âú®ÂÅáÂÆöÂ≠òÂú®‰∏Ä‰∏™Á®≥ÊÄÅÂèçÂ∫îÊù°‰ª∂‰∏ãÊé®ÂØºÂá∫Êù•ÁöÑÔºåÂÖ∂‰∏≠ Km ÂÄºÁß∞‰∏∫Á±≥Ê∞èÂ∏∏Êï∞ÔºåVmaxÊòØÈÖ∂Ë¢´Â∫ïÁâ©È•±ÂíåÊó∂ÁöÑÂèçÂ∫îÈÄüÂ∫¶Ôºå[S]‰∏∫Â∫ïÁâ©ÊµìÂ∫¶„ÄÇ KmÂÄºÁöÑÁâ©ÁêÜÊÑè‰πâ‰∏∫ÂèçÂ∫îÈÄüÂ∫¶ÔºàvÔºâËææÂà∞1/2VmaxÊó∂ÁöÑÂ∫ïÁâ©ÊµìÂ∫¶ÔºàÂç≥Km=[S]ÔºâÔºåÂçï‰Ωç‰∏ÄËà¨‰∏∫mol/LÔºåÂè™Áî±ÈÖ∂ÁöÑÊÄßË¥®ÂÜ≥ÂÆöÔºåËÄå‰∏éÈÖ∂ÁöÑÊµìÂ∫¶Êó†ÂÖ≥„ÄÇÂèØÁî®KmÁöÑÂÄºÈâ¥Âà´‰∏çÂêåÁöÑÈÖ∂„ÄÇ
 ‰ªäÂ§©Ë¶Å‰ªãÁªçÁöÑËøôÁØáÊñáÁ´†ÊèêÂá∫‰∫Ü‰∏Ä‰∏™ÁÆóÊ≥ïÔºåRÂåÖÊòØÔºöM3Drop Ôºå ÊñáÁ´†ÊòØÔºöModelling dropouts for feature selection in scRNASeq experiments
ÊåëÈÄâÈáçË¶ÅÂü∫Âõ† ÁõÆÂâçÂ∑≤ÊúâÁöÑÂØªÊâæÂçïÁªÜËÉûËΩ¨ÂΩïÁªÑÊµãÂ∫èÊï∞ÊçÆ‰∏≠ÁöÑÈáçË¶ÅÂü∫Âõ†Ôºàfeature selectionÔºâÁöÑÊñπÊ≥ïÈÉΩ‰∏çÂ§üÂ•ΩÔºåÊØîÂ¶Ç scLVM ‰∏ªË¶ÅÊòØÊ†πÊçÆÂÖàÈ™åÂü∫Âõ†ÈõÜÔºåÊØîÂ¶Çcell-cycle or apoptosisÊù•Âå∫ÂàÜÁªÜËÉû„ÄÇ‰∏éÊ≠§Áõ∏ÂèçÔºåÂü∫‰∫é highly variable genes (HVG) ÁöÑÊñπÊ≥ïÊåëÈÄâÂà∞ÁöÑÂèòÂåñÈáèÂ§ßÁöÑÈÇ£‰∫õÂü∫Âõ†ÂæàÂèØËÉΩÊòØÊäÄÊúØÂ∏¶Êù•ÁöÑËØØÂ∑Æ„ÄÇËÄå‰∏î‰ΩéË°®ËææÈáèÂü∫Âõ†ÁöÑÂèòÂä®ÂæÄÂæÄÂ§ß‰∫éÈ´òË°®ËææÈáèÂü∫Âõ†ÔºåËÄå‰∏îÊâÄË∞ìÁöÑË°®ËææÂèòÂåñÂ§ß‰πüÂπ∂Ê≤°ÊúâÂæàÂ•ΩÁöÑÁîüÁâ©Â≠¶Ëß£Èáä„ÄÇ ‰∏Ä‰∏™ÊØîËæÉÂ•ΩÁêÜËß£ÁöÑÊ¶ÇÂøµÊòØÂ∑ÆÂºÇÂü∫Âõ†Ôºå‰ΩÜÊòØÈúÄË¶ÅÈ¢ÑÂÖàÊääÁªÜËÉûÁæ§‰ΩìÂàÜÁªÑÂêéËøõË°åÊØîËæÉÊâçËÉΩÂæóÂà∞ÔºåËÄåÂæàÂ§öÊó∂ÂÄôÁªÜËÉûÂ§™Áõ∏‰ºº‰∫ÜÔºåÊ≤°ÂäûÊ≥ïÂæàÂ•ΩÁöÑÂàÜÂºÄ„ÄÇÂÉèPCAÊàñËÄÖt-SNEËøôÊ†∑ÁöÑÈôçÁª¥ÊñπÊ≥ï‰πüÂèØ‰ª•Áî®Êù•ÊåëÈÄâÈáçË¶ÅÂü∫Âõ†Ôºå‰ΩÜÂÆÉ‰ª¨‰πüÂèóÂà∂‰∫éÁ≥ªÁªüËØØÂ∑ÆÊàñËÄÖÊâπÊ¨°ËØØÂ∑ÆÁ≠âÁ≠â„ÄÇ dropoutÊòØscRNASeqÊï∞ÊçÆÁöÑ‰∏ÄÂ§ßÁâπÁÇπÔºåÂ∞±ÊòØÂæàÂ§öÂü∫Âõ†Âú®Êüê‰∫õÁªÜËÉûÊ†πÊú¨Â∞±‰∏çË°®ËææÔºå‰ΩÜÊòØÂú®Âè¶Â§ñÁöÑÁªÜËÉûÂç¥È´òË°®Ëææ„ÄÇËøôÁØáÊñáÁ´†‰ΩúËÄÖÂØπÂÖ®ÈïøËΩ¨ÂΩïÊú¨Êï∞ÊçÆÂíåÂü∫‰∫éUMIÁöÑË°®ËææÈáèÊï∞ÊçÆÂàÜÂà´ÊèêÂá∫‰∫ÜÂØπÂ∫îÁöÑËß£ÂÜ≥ÊñπÊ°àÔºåMichaelis-Menten equation Âíå depth adjusted negative binomial (DANB) „ÄÇ
ÂçïÁªÜËÉûËΩ¨ÂΩïÁªÑÊï∞ÊçÆÈáåÈù¢ÁöÑdropoutsÂèØ‰ª•ËææÂà∞50%Ôºå‰ΩÜÊòØÈÄöÂ∏∏ËÆ§‰∏∫Ëøô‰∏™dropoutsÊòØÂõ†‰∏∫Âú®ÊñáÂ∫ìÊûÑÂª∫ÁöÑËøáÁ®ã‰∏≠ÔºåÊúâÈÉ®ÂàÜÂü∫Âõ†Ê≤°ÊúâË¢´ÊàêÂäüÁöÑÂèçËΩ¨ÂΩïÔºåÊòØ‰∏Ä‰∏™ÈÖ∂‰øÉÂèçÂ∫î„ÄÇ ÊâÄ‰ª•‰ΩúËÄÖÁî®Michaelis-Menten Êù•Âª∫Ê®°„ÄÇ
ÊØîËæÉ9Áßç feature selection ÊñπÊ≥ï ‰ΩøÁî®ÂÆÉ‰ª¨ÂàÜÂà´ÂØπÂü∫Âõ†ÊéíÂ∫èÔºåÁÆóÊ≥ïÂ¶Ç‰∏ãÔºö
1 2 3 4 5 6 7 8  bythemagnitudeoftheirloadingsinprincipalcomponentanalysis(PCA)bythestrengthoftheirmostnegativegene-genecorrelation(Cor)bytheirrelativeGiniindex(Gini)M3Dropdropouts-meanexpressioncurve(M3Drop)thesquaredcoefficientofvariation(CV2)meanexpressionrelationship(HVG)thedispersion-meanexpressionrelationshipfitbyDANB(NBDisp)thedropouts-meanexpressionrelationshipfitbyDANB(NBDrop).  Ëøô‰∫õÁÆóÊ≥ïÈÉΩ‰∏çÈúÄË¶ÅÈ¢ÑÂÖàÂØπÊ†∑Êú¨ËøõË°åÂàÜÁ±ªÔºåÊòØÊó†ÁõëÁù£ÁöÑÁÆóÊ≥ï„ÄÇ
1 2 3  differentially variable (DV)genes highly variable (HV) genes differentially expressed (DE) genes   ÂçïÁªÜËÉûËΩ¨ÂΩïÁªÑÊï∞ÊçÆÁöÑbatch effectsÊØîËæÉ‰∏•ÈáçÔºåÊâÄ‰ª• feature selection ËøáÁ®ãÁöÑ‰∏Ä‰∏™‰∏ªË¶ÅÁõÆÁöÑÂ∞±ÊòØÈôç‰ΩéÊäÄÊúØËØØÂ∑ÆÁöÑÂΩ±ÂìçÔºåÈõÜ‰∏≠Âú®ÊúâÁîüÁâ©Â≠¶ÊÑè‰πâÁöÑÂ∑ÆÂºÇ‰∏äÈù¢„ÄÇ]]></description>
</item>
</channel>
</rss>
